![FDA approves new Alzheimer's treatment, donanemab from Eli Lilly](https://assets1.cbsnewsstatic.com/hub/i/r/2023/07/17/346a3685-d452-4a57-9056-3d0276b389ef/thumbnail/1200x630/b7058d56275b3f9797db08fdab421175/ap23195650522833.jpg?v=57e8061b2038d609da26e467de5ddfb8)
FDA approves new Alzheimer's treatment, donanemab from Eli Lilly
CBSN
The Food and Drug Administration approved a new Alzheimer's treatment called donanemab on Tuesday, clearing the way for the third addition to a new class of drugs aimed at slowing the brain's decline in patients facing the early stages of the disease.
Branded as Kisunla by drugmaker Eli Lilly, donanemab's approval follows years of setbacks and delays in getting the experimental Alzheimer's treatment to market, despite promising clinical trial results.
Eli Lilly says the drug will be available within weeks following the approval.
![](/newspic/picid-6252001-20240703212148.jpg)
A case of H5 influenza, also known as bird flu or avian influenza, has been confirmed in a man who was working at a dairy farm in northeastern Colorado. That's according to the Colorado Department of Public Health and Environment, which said it is the fourth confirmed human case in the United States since an outbreak among cows that appears to have started in March.